Freshly prepared ascorbate inhibited mitosis and induced chromosome aberrations in cultured Chinese hamster ovary cells. Cu(II) and Mn(II) (10(-4) or 10(-5) M) enhanced both actions. Fe(II) and Fe(III) (10(-4) or 10(-5) M) reduced or abolished the mitosis-inhibiting action of ascorbate. At 10(-4) M, Fe(II) and Fe(III) strongly enhanced the chromosome-damaging capacity of ascorbate. Up to 100% of all examined metaphase plates had multiple chromosome exchanges or breaks. Since the cytostatic and clastogenic effect of ascorbate of H2O2 to induce chromosome aberrations was examined. H2O2 and a H2O2: Fe(II) mixture (Fenton reagent) induced chromosome breaks and exchanges but to a lesser degree than did ascorbate: Cu(II), Mn(II), Fe(II), or Fe(III) mixtures. Whether the strong chromosome damaging capacity of ascorbate plus transition metals as seen in the in vitro test system poses a health hazard only properly designed in vivo studies can reveal.

Download full-text PDF

Source

Publication Analysis

Top Keywords

feii feiii
12
action ascorbate
8
ascorbate transition
8
transition metals
8
induced chromosome
8
chromosome aberrations
8
cuii mnii
8
10-4 10-5
8
capacity ascorbate
8
ascorbate
7

Similar Publications

New insights into the Fe(III)-activated peroxyacetic acid: oxidation properties and mechanism.

Environ Res

January 2025

Ministry of Ecology and Environment South China Institute of Environmental Sciences, Guangzhou 510655, China; Key Laboratory of Water Environmental Simulation and Pollution Control, Ministry of Ecology and Environment, Guangzhou 510655, China. Electronic address:

Iron-activated peroxyacetic acid (PAA) represents an innovative advanced oxidation process (AOP). However, the efficiency of PAA activation by Fe(III) is often underestimated due to the widespread assumption that Fe(III) exhibits much lower ability than Fe(II) to activate PAA. Herein, the oxidative degradation of Rhodamine B (RhB) by Fe(III)-activated PAA process was investigated, and some new insights into the performance and mechanism of the Fe(III)/PAA system were presented.

View Article and Find Full Text PDF

Iron (Fe) minerals possess a huge specific surface area and high adsorption affinity, usually considered as "rust tanks" of organic carbon (OC), playing an important role in global carbon storage. Microorganisms can change the chemical form of Fe by producing Fe-chelating agents such as side chains and form a stable complex with Fe(III), which makes it easier for microorganisms to use. However, in seasonal frozen soil thawing, the succession of soil Fe-cycling microbial communities and their coupling relationship with Fe oxides and Fe-bound organic carbon (Fe-OC) remains unclear.

View Article and Find Full Text PDF

The role of histidine buffer in the iron-catalyzed formation of oxidizing species in pharmaceutical formulations: Mechanistic studies.

J Pharm Sci

January 2025

Department of Pharmaceutical Chemistry, University of Kansas, 2093 Constant Avenue, Lawrence, KS 66047, USA. Electronic address:

Iron-catalyzed oxidation reactions are common degradation pathways in pharmaceutical formulations. Buffers can influence oxidation reactions promoted by iron (Fe) and hydrogen peroxide (H₂O₂). However, mechanistically, the specific role of buffers in such reactions is not well understood.

View Article and Find Full Text PDF

The low sulfur selectivity of Fe-based HS-selective catalytic oxidation catalysts is still a problem, especially at a high O content. This is alleviated here through anchoring FeO nanoclusters on UiO-66 via the formation of Fe-O-Zr bonds. The introduced FeO species exist in the form of Fe and Fe.

View Article and Find Full Text PDF

A critical analysis of the potential of iron heterobimetallic complexes in anticancer research.

J Inorg Biochem

March 2025

Centro de Química Estrutural, Institute of Molecular Sciences, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal.

Due to their diverse chemical properties and high ability to interact with biological molecules and cellular processes, transition metal-based compounds have emerged as promising candidates for cancer therapy. Iron complexes are among them, however, there is a gap in the comprehensive analysis of heterometallic iron complexes in the anticancer field. This review aims to fill this gap by summarizing recent progress in the study of Fe(II) and Fe(III) heterobimetallic complexes for anticancer applications and to gather important insights and future perspectives, with special emphasis on their theranostic capabilities.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!